Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT01088360
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to compare the incidence rates of targeted infections, malignancies and mortality among patients with rheumatoid arthritis who are treated with abatacept and those who are treated with other anti-rheumatic medications.
Official title: An Observational Cohort to Assess Safety and Outcomes in Patients Treated With Abatacept and Other Anti-Rheumatic Therapies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20000
Start Date
2005-03-31
Completion Date
2029-06-30
Last Updated
2019-01-18
Healthy Volunteers
No